HPV-induced Cancers
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tolerance and Effectiveness of C14 on HPV Infection (NCT06672653) | MGB Pharma | 2024-11-15 |
| Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers (NCT02526316) | Oryx GmbH & Co. KG | 2015-06-01 |
| Immune Therapy of HPV-induced Cancers (NCT01462838) | Oryx GmbH & Co. KG | 2011-08-01 |
Track HPV-induced Cancers automatically
Every clearance here is in the API, with alerts when new ones post.